Goldman Sachs Upgrades Konecranes to Buy

Goldman Sachs analyst Daniela Costa upgrades Konecranes (OTC:KNCRY) from Neutral to Buy.

byBenzinga Newsdesk

July 15, 2021

1 minute read

Goldman Sachs analyst Daniela Costa upgrades Konecranes (OTC:KNCRY) from Neutral to Buy.

Coinbase Customers Are ‘HODLing’ While Company Cuts Costs: What 5 Analysts Are Saying After Q3 Earnings

By Chris Katje

Today, 2:57 PM

Analysts are reacting to the third-quarter earnings report from Coinbase Global (NASDAQ: COIN).

COIN

Rigel Announces U.S. FDA Approval Of REZLIDHIA (olutasidenib) For Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia With a Susceptible IDH1 Mutation

By Michael Horton

Today, 2:57 PM

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that the U.S. Food and Drug Administration (FDA) has approved REZLIDHIA™ (olutasidenib) capsules for the treatment of adult patients with relapsed or

RIGL

Alight Q2 Sales $672.00M Up From $647.00M YoY

By Benzinga Newsdesk

Today, 2:57 PM

Alight (NYSE:ALIT) reported $672.00 million in sales this quarter. This is a 3.86 percent increase over sales of $647.00 million the same period last year.

ALIT

EV Week In Review: Tesla’s China Woes, Giga Berlin to Soon Come Online, Earnings Fail to Lift Nio, Lordstown On Track, Fisker’s Debt Financing and More

By Shanthi Rexaline

Today, 2:57 PM

The EV space was brimming with activity in the week ended Aug. 13, with fund raising and earnings dominating the headlines.

FSR

Goldman Sachs Upgrades Konecranes to Buy

Related Posts

Coinbase Customers Are ‘HODLing’ While Company Cuts Costs: What 5 Analysts Are Saying After Q3 Earnings

Rigel Announces U.S. FDA Approval Of REZLIDHIA (olutasidenib) For Treatment Of Adult Patients With Relapsed Or Refractory Acute Myeloid Leukemia With a Susceptible IDH1 Mutation

Alight Q2 Sales $672.00M Up From $647.00M YoY

EV Week In Review: Tesla’s China Woes, Giga Berlin to Soon Come Online, Earnings Fail to Lift Nio, Lordstown On Track, Fisker’s Debt Financing and More